Literature DB >> 31073626

The iHOPE-20 study: mortality in first episode psychosis-a 20-year follow-up of the Dublin first episode cohort.

Roisin Doyle1, Donal O'Keeffe2, Ailish Hannigan3, Anthony Kinsella2, Caragh Behan2, Aine Kelly4, Ann Sheridan5, Kevin Madigan6,7, Elizabeth Lawlor2,6, Mary Clarke2,8.   

Abstract

PURPOSE: Increased mortality rates have been found in those with a diagnosis of psychosis; studies suggest a shortened life expectancy of up to 20 years less than that of the general population. This study aimed to investigate the mortality of a first episode psychosis cohort at 20-year follow-up, compare it to that of the general Irish population, and explore whether the mortality gap has changed over time.
METHODS: 171 individuals diagnosed with a first episode psychosis identified between 1995 and 1999 in a community mental health service were traced. Mortality was established by matching death certificates to deceased cohort members (using name, age at date of death, and address at date of death). Date of first presentation to service was used as date of entry point and date of death or end of follow-up as the end point.
RESULTS: Of the 171 cases there were 20 deaths during follow-up. Nine deaths were attributed to natural causes; 7 to unnatural causes; and 4 were unknown. Comparing standardised mortality rates at 20-year follow-up to those at 12 year showed a reduction in rates over time.
CONCLUSION: Findings suggest that the mortality gap in people with schizophrenia and other psychoses remains high, especially in young males.

Entities:  

Keywords:  20-year follow-up; Epidemiological; First episode psychosis; Incidence cohort; Mortality

Mesh:

Year:  2019        PMID: 31073626     DOI: 10.1007/s00127-019-01721-x

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  20 in total

1.  Mortality in people with psychotic disorders in Finland: A population-based 13-year follow-up study.

Authors:  Jaakko Keinänen; Outi Mantere; Niina Markkula; Krista Partti; Jonna Perälä; Samuli I Saarni; Tommi Härkänen; Jaana Suvisaari
Journal:  Schizophr Res       Date:  2017-05-09       Impact factor: 4.939

2.  A widening longevity gap between people with schizophrenia and general population: A literature review and call for action.

Authors:  Ellen E Lee; Jinyuan Liu; Xin Tu; Barton W Palmer; Lisa T Eyler; Dilip V Jeste
Journal:  Schizophr Res       Date:  2017-09-28       Impact factor: 4.939

3.  Association of Secondary Preventive Cardiovascular Treatment After Myocardial Infarction With Mortality Among Patients With Schizophrenia.

Authors:  Pirathiv Kugathasan; Henriette Thisted Horsdal; Jørgen Aagaard; Svend Eggert Jensen; Thomas Munk Laursen; René Ernst Nielsen
Journal:  JAMA Psychiatry       Date:  2018-12-01       Impact factor: 21.596

4.  Excess mortality of schizophrenia. A meta-analysis.

Authors:  S Brown
Journal:  Br J Psychiatry       Date:  1997-12       Impact factor: 9.319

5.  Sudden death among young people with first-episode psychosis: An 8-10 year follow-up study.

Authors:  Jo Robinson; Meredith Harris; Sue Cotton; Ally Hughes; Philippe Conus; Martin Lambert; Benno G Schimmelmann; Patrick McGorry
Journal:  Psychiatry Res       Date:  2010-04-21       Impact factor: 3.222

6.  Mortality in schizophrenia and other psychoses: a 10-year follow-up of the ӔSOP first-episode cohort.

Authors:  Ulrich Reininghaus; Rina Dutta; Paola Dazzan; Gillian A Doody; Paul Fearon; Julia Lappin; Margaret Heslin; Adanna Onyejiaka; Kim Donoghue; Ben Lomas; James B Kirkbride; Robin M Murray; Tim Croudace; Craig Morgan; Peter B Jones
Journal:  Schizophr Bull       Date:  2014-09-27       Impact factor: 9.306

7.  A randomized trial of medical care management for community mental health settings: the Primary Care Access, Referral, and Evaluation (PCARE) study.

Authors:  Benjamin G Druss; Silke A von Esenwein; Michael T Compton; Kimberly J Rask; Liping Zhao; Ruth M Parker
Journal:  Am J Psychiatry       Date:  2009-12-15       Impact factor: 18.112

8.  Increasing mortality gap for patients diagnosed with schizophrenia over the last three decades--a Danish nationwide study from 1980 to 2010.

Authors:  René Ernst Nielsen; Anne Sofie Uggerby; Signe Olrik Wallenstein Jensen; John Joseph McGrath
Journal:  Schizophr Res       Date:  2013-03-21       Impact factor: 4.939

Review 9.  A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?

Authors:  Sukanta Saha; David Chant; John McGrath
Journal:  Arch Gen Psychiatry       Date:  2007-10

10.  Schizophrenia, antipsychotics, and the metabolic syndrome: is there a silver lining?

Authors:  Gary Remington
Journal:  Am J Psychiatry       Date:  2006-07       Impact factor: 19.242

View more
  2 in total

1.  Digital smartphone intervention to recognise and manage early warning signs in schizophrenia to prevent relapse: the EMPOWER feasibility cluster RCT.

Authors:  Andrew I Gumley; Simon Bradstreet; John Ainsworth; Stephanie Allan; Mario Alvarez-Jimenez; Maximillian Birchwood; Andrew Briggs; Sandra Bucci; Sue Cotton; Lidia Engel; Paul French; Reeva Lederman; Shôn Lewis; Matthew Machin; Graeme MacLennan; Hamish McLeod; Nicola McMeekin; Cathy Mihalopoulos; Emma Morton; John Norrie; Frank Reilly; Matthias Schwannauer; Swaran P Singh; Suresh Sundram; Andrew Thompson; Chris Williams; Alison Yung; Lorna Aucott; John Farhall; John Gleeson
Journal:  Health Technol Assess       Date:  2022-05       Impact factor: 4.106

2.  Mortality After the First Diagnosis of Schizophrenia-Spectrum Disorders: A Population-based Retrospective Cohort Study.

Authors:  Paul Kurdyak; Emilie Mallia; Claire de Oliveira; Andre F Carvalho; Nicole Kozloff; Juveria Zaheer; Wanda M Tempelaar; Kelly K Anderson; Christoph U Correll; Aristotle N Voineskos
Journal:  Schizophr Bull       Date:  2021-04-29       Impact factor: 9.306

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.